Detail akcie Cannabix Tech online

Business Summary: Cannabix Technologies Inc. is a developer of marijuana and alcohol breathalyzer technologies for workplaces, law enforcement and other settings. Breath testing for delta-9 tetrahydrocannabinol (THC) (the primary psychoactive ingredient in cannabis) focuses on marijuana use. It is engaged in developing novel wall-mounted alcohol screening devices targeted primarily for workplace settings. It develops contactless breath alcohol detection devices. Its products include Cannabix Marijuana Breath Test (MBT) and BreathLogix Alcohol Breathalyzer. Its breath testing consists of Cannabis Breath Testing and Workplace Alcohol Testing. MBT utilizes a handheld Breath Collection Unit to capture the breath sample into a Cannabix Breath Cartridge that is shipped for laboratory analysis. The BreathLogix alcohol screening product is an autonomous alcohol screening system that enables the screening of employees, contractors and visitors in industries, such as mining, construction, oil and gas, and others.
Financial Summary: BRIEF: For the six months ended 31 October 2025, Cannabix Technologies Inc revenues increased from C$0K to C$123K. Net loss increased 96% to C$3.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development increase of 89% to C$2.4M (expense), Advertising and promotion increase from C$51K to C$152K (expense).